IBN Sina pharma’s profit jumps nearly 24pc

Business Desk :
IBN Sina Pharmaceutical Industry Ltd’s profit jumped nearly 24 per cent in the financial year that ended on June 30.
Consolidated earnings per share stood at Tk 19.39 in the year, up from Tk 15.66 a year ago, said the company in a filing on the Dhaka Stock Exchange on Tuesday.
Consolidated net asset value per share was Tk 83.36 and consolidated net operating cash flow per share was Tk 13.40 in 2021-22, compared to Tk 68.69 and Tk 17.67, respectively, in the previous financial year.